MoneyWorks4Me

With no major difference for the quarter endedJune 2024 , the total revenue stood at Rs. 859.57  millions.Net profit declined -0.64% to Rs. 670.56 millions from Rs. 674.87 millions.Operating profit for the quarter ended June 2024 decreased to 747.97 millions as compared to 760.26 millions of corresponding quarter ended June 2023.


(Rs. in Million)


  Quarter ended Year to Date Year ended
  202406 202306 % Var 202406 202306 % Var 202403 202303 % Var
Sales 859.57 853.49 0.71 859.57 853.49 0.71 3654.69 3115.29 17.31
Other Income 538.76 512.49 5.13 538.76 512.49 5.13 588.09 98.08 499.60
PBIDT 747.97 760.26 -1.62 747.97 760.26 -1.62 1639.95 846.96 93.63
Interest 0.22 0.35 -37.14 0.22 0.35 -37.14 1.57 1.35 16.30
PBDT 747.75 759.91 -1.60 747.75 759.91 -1.60 1448.90 845.61 71.34
Depreciation 26.19 25.07 4.47 26.19 25.07 4.47 108.98 102.83 5.98
PBT 721.56 734.84 -1.81 721.56 734.84 -1.81 1339.92 742.78 80.39
TAX 51.00 59.97 -14.96 51.00 59.97 -14.96 258.69 187.51 37.96
Deferred Tax 1.54 -0.68 -326.47 1.54 -0.68 -326.47 -10.82 4.97 -317.71
PAT 670.56 674.87 -0.64 670.56 674.87 -0.64 1081.23 555.27 94.72
Equity 223.65 223.65 0.00 223.65 223.65 0.00 223.65 223.65 0.00
PBIDTM(%) 87.02 89.08 -2.31 87.02 89.08 -2.31 44.87 27.19 65.05
Peers
Company Name CMP
Sun Pharma. Inds. 1820.00
Dr. Reddys Labs. 1236.00
Cipla 1350.00
Lupin 2042.00
Zydus Lifesciences 1163.35
View more..